inibidores de pirazolopirimidona e pirazolopiridona de tanquirase

There are provided compounds of the formula or a pharmaceutically acceptable salt thereof, wherein Q, R1 and R2 are as defined herein. The compounds of formula I are useful in the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors KYUNGJIN KIM, MARK ZAK, JIANWEN FENG, GUILING ZHAO, NANCY-ELLEN HAYNES, JOHANNES CORNELIUS HERMANN, JIN-JUN LIU, LIN YI, NATHAN ROBERT SCOTT
Format Patent
LanguagePortuguese
Published 27.06.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract There are provided compounds of the formula or a pharmaceutically acceptable salt thereof, wherein Q, R1 and R2 are as defined herein. The compounds of formula I are useful in the treatment of cancer.
AbstractList There are provided compounds of the formula or a pharmaceutically acceptable salt thereof, wherein Q, R1 and R2 are as defined herein. The compounds of formula I are useful in the treatment of cancer.
Author JIN-JUN LIU
NANCY-ELLEN HAYNES
JIANWEN FENG
JOHANNES CORNELIUS HERMANN
LIN YI
NATHAN ROBERT SCOTT
KYUNGJIN KIM
GUILING ZHAO
MARK ZAK
Author_xml – fullname: KYUNGJIN KIM
– fullname: MARK ZAK
– fullname: JIANWEN FENG
– fullname: GUILING ZHAO
– fullname: NANCY-ELLEN HAYNES
– fullname: JOHANNES CORNELIUS HERMANN
– fullname: JIN-JUN LIU
– fullname: LIN YI
– fullname: NATHAN ROBERT SCOTT
BookMark eNrjYmDJy89L5WRwzMzLTMpMyS9KLVZISVUoyCxKrMrPyQfSmblA4bxEBVRBsBBQYUliXmEpULw4lYeBNS0xpziVF0pzM6i6uYY4e-imFuTHpxYXJCan5qWWxDsFGRoaGRiaGBgbmBgaOBoZE6sOACv6Ndg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID BR112014030410A2
GroupedDBID EVB
ID FETCH-epo_espacenet_BR112014030410A23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Portuguese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_BR112014030410A23
Notes Application Number: BR20141130410
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170627&DB=EPODOC&CC=BR&NR=112014030410A2
ParticipantIDs epo_espacenet_BR112014030410A2
PublicationCentury 2000
PublicationDate 20170627
PublicationDateYYYYMMDD 2017-06-27
PublicationDate_xml – month: 06
  year: 2017
  text: 20170627
  day: 27
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies F. HOFFMANN-LA ROCHE AG
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
Score 3.1018882
Snippet There are provided compounds of the formula or a pharmaceutically acceptable salt thereof, wherein Q, R1 and R2 are as defined herein. The compounds of formula...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title inibidores de pirazolopirimidona e pirazolopiridona de tanquirase
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170627&DB=EPODOC&locale=&CC=BR&NR=112014030410A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NS8NAEB1KFfWmVfGz5KC5BZvEJu0hSPNFEfpBqNJbyXa30EsSbETw1_smpGovegnLsCybhdl5b3feLNGdAghw3L5lSClBUFx8hG2vjDQVK2FLC6CcxcmjsTN8eXyed-cNyrZamKpO6EdVHBEetYS_l9V-XfwcYoVVbuXmQaxhyp_imRfqNTvmWjCWq4e-F00n4STQg8DzE32ceIAVzCVA3s3OAFv2HkNprrUfvfqsTCl-h5X4mPanGDErT6hRlC06DLavr7XoYFRfeqNZ-9_mlAbrjNVyOTiyJpXGl-SfOWue-HEuCVCt7RorEzoCAXLGLyLWGd3H0SwYGpjL4vvnF36yO3X7nJpZnqkL0kzpKAkP7Crlggb2RW-JeGOCoVhpb9URl9T-e6yr_zpc0xEvKqdGWe4NNcu3d3WLIFyKdrVyX4xwilU
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NT4NAEJ001VhvWjV-Vg7KjVjAQnsgpkAJaqENQdMbYbtL0gsQizHx1ztDqNqLXshmstksm8zOe7vzZgFuBIIAwxxpCuccCYqJH6brmZKmLGM61xCUkzg5CA3_5f5pMVi0IN9oYeo6oR91cUT0qCX6e1Xv1-XPIZZb51au79gKTcWDF1uu3LBjqgWjmbJrW5P5zJ05suNYdiSHkYWwgrgEkne1P8Yte8ekCr0En15tUqaUv8OKdwC7cxwxrw6hVVZd6Dib19e6sBc0l97YbPxvfQTjVU5quQI5ssSFRJfknwVpnuhxLo6gWto21ibsiAiQMn4xYh3DrTeJHV_BuSTfP5_Y0fbU9RNo50UuTkFSuSE4euBACBNp4IgNlxhvVGQoWjrM-uwMen-Pdf5fh2vo-HEwTaaP4fMF7NMCU5qUZl5Cu3p7F1cYkCvWq1fxCy0sjUI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=inibidores+de+pirazolopirimidona+e+pirazolopiridona+de+tanquirase&rft.inventor=KYUNGJIN+KIM&rft.inventor=MARK+ZAK&rft.inventor=JIANWEN+FENG&rft.inventor=GUILING+ZHAO&rft.inventor=NANCY-ELLEN+HAYNES&rft.inventor=JOHANNES+CORNELIUS+HERMANN&rft.inventor=JIN-JUN+LIU&rft.inventor=LIN+YI&rft.inventor=NATHAN+ROBERT+SCOTT&rft.date=2017-06-27&rft.externalDBID=A2&rft.externalDocID=BR112014030410A2